GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » 1-Year Sharpe Ratio

Hualan Biological Engineering (SZSE:002007) 1-Year Sharpe Ratio : -0.43 (As of Jun. 26, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2025-06-26), Hualan Biological Engineering's 1-Year Sharpe Ratio is -0.43.


Competitive Comparison of Hualan Biological Engineering's 1-Year Sharpe Ratio

For the Biotechnology subindustry, Hualan Biological Engineering's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Engineering's 1-Year Sharpe Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's 1-Year Sharpe Ratio falls into.


;
;

Hualan Biological Engineering 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.


Hualan Biological Engineering  (SZSE:002007) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Hualan Biological Engineering 1-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's 1-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Engineering Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
Chen Zheng Yue Executives
Fan Bei Directors, executives
Pan Ruo Wen Executives
Xie Jun Min Directors, executives
An Wen Qi Executives
An Kang Directors, executives
Ma Xiao Wei Executives
Zhang Bao Xian Executives
An Wen Jue Director
Liu Jun Executives
Wang Qi Ping Directors, executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors

Hualan Biological Engineering Headlines

No Headlines